Sirna Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Sirna Therapeutics, Inc. - overview
Established
1992
Location
Boulder, CO, US
Primary Industry
Biotechnology
About
Founded in 1992 and based in Colorado, US, Sirna Therapeutics, Inc. operates as a biotechnology company that develops therapeutics based on ribonucleic acid interference technology for human diseases including dermatology, respiratory, metabolism, neurology, ocular, oncology and antiviral conditions.
Current Investors
Oxford Bioscience Partners, Sprout Group, TVM Capital Life Science
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Bioinformatics, Dermatology, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.